Therapeutics in the pipeline targeting α-synuclein for Parkinson's disease

HG Jasutkar, SE Oh, MM Mouradian - Pharmacological reviews, 2022 - ASPET
Parkinson's disease (PD) is the second most common neurodegenerative disorder and the
fastest growing neurologic disease in the world, yet no disease-modifying therapy is …

Neuropathology of sporadic Parkinson's disease: evaluation and changes of concepts

KA Jellinger - Movement disorders, 2012 - Wiley Online Library
Abstract Parkinson's disease (PD), one of the most frequent neurodegenerative disorders, is
no longer considered a complex motor disorder characterized by extrapyramidal symptoms …

Tissue transglutaminase: A multifunctional and multisite regulator in health and disease

Z Yao, Y Fan, L Lin, RE Kellems… - Physiological …, 2024 - journals.physiology.org
Tissue transglutaminase (TG2) is a widely distributed multifunctional protein involved in a
broad range of cellular and metabolic functions carried out in a variety of cellular …

Parkinson's disease is associated with altered expression of CaV1 channels and calcium-binding proteins

MJ Hurley, B Brandon, SM Gentleman, DT Dexter - Brain, 2013 - academic.oup.com
In Parkinson's disease oxidative stress and calcium-induced excitotoxicity have been
considered important mechanisms leading to cell death for decades, but the factors that …

The protein disulfide isomerase family: from proteostasis to pathogenesis

M Matsusaki, S Kanemura, M Kinoshita, YH Lee… - … et Biophysica Acta (BBA …, 2020 - Elsevier
In mammalian cells, nearly one-third of proteins are inserted into the endoplasmic reticulum
(ER), where they undergo oxidative folding and chaperoning assisted by approximately 20 …

Molecular changes in the postmortem parkinsonian brain

D Toulorge, AHV Schapira, R Hajj - Journal of neurochemistry, 2016 - Wiley Online Library
Parkinson disease (PD) is the second most common neurodegenerative disease after
Alzheimer disease. Although PD has a relatively narrow clinical phenotype, it has become …

T cell epitopes and post-translationally modified epitopes in type 1 diabetes

JW McGinty, ML Marré, V Bajzik, JD Piganelli… - Current diabetes …, 2015 - Springer
Abstract Type 1 diabetes (T1D) is an autoimmune disease in which progressive loss of self-
tolerance, evidenced by accumulation of auto-antibodies and auto-reactive T cells that …

β cell ER stress and the implications for immunogenicity in type 1 diabetes

ML Marré, EA James, JD Piganelli - Frontiers in cell and …, 2015 - frontiersin.org
Type 1 diabetes (T1D) is a chronic autoimmune disease characterized by hyperglycemia
due to progressive immune-mediated destruction of insulin-producing pancreatic islet β …

Inherent ER stress in pancreatic islet β cells causes self-recognition by autoreactive T cells in type 1 diabetes

ML Marré, JL Profozich, JT Coneybeer, X Geng… - Journal of …, 2016 - Elsevier
Abstract Type 1 diabetes (T1D) is an autoimmune disease characterized by pancreatic β cell
destruction induced by islet reactive T cells that have escaped central tolerance. Many …

Pre-Clinical studies identifying molecular pathways of neuroinflammation in Parkinson's disease: a systematic review

M Fathi, K Vakili, S Yaghoobpoor… - Frontiers in Aging …, 2022 - frontiersin.org
Parkinson's disease (PD), the second most common neurodegenerative disorder, is
characterized by neuroinflammation, formation of Lewy bodies, and progressive loss of …